Kyzatrex wac red book price?

Kyzatrex (bexagliflozin) Pricing Information

Information regarding the specific "red book" price for Kyzatrex (bexagliflozin) is not readily available in the provided text. The red book is a catalog used by pharmacies and payers to determine drug reimbursement rates.

When Might Pricing Information Become Publicly Available?

Drug pricing and reimbursement details typically emerge following a drug's approval and market launch. Information on the list price, wholesale acquisition cost (WAC), and net price is usually disclosed by the manufacturer or becomes accessible through pharmaceutical pricing databases.

What is Bexagliflozin?

Bexagliflozin is an investigational medication that targets SGLT2 to lower blood glucose levels in adults with type 2 diabetes. It is a once-daily oral tablet.

How Does Bexagliflozin Work?

Bexagliflozin is a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2). By inhibiting SGLT2 in the kidneys, it reduces the reabsorption of glucose, leading to increased urinary glucose excretion and consequently, lower blood glucose levels [1].

What is the Status of Bexagliflozin Approval?

Bexagliflozin has been submitted for review by the U.S. Food and Drug Administration (FDA). The FDA has issued Complete Response Letters (CRLs) regarding the new drug application (NDA) for bexagliflozin, indicating that the agency has not yet approved the drug [2]. This means it is not currently available on the market.

What are the Potential Risks and Side Effects?

As an investigational drug, potential risks and side effects of bexagliflozin would be identified through clinical trials. SGLT2 inhibitors as a class can be associated with certain side effects, and specific risks for bexagliflozin would be detailed in its prescribing information upon approval.

What Other SGLT2 Inhibitors Are Available?

Several other SGLT2 inhibitors are approved and available for the treatment of type 2 diabetes. These include empagliflozin, canagliflozin, and dapagliflozin [3].

Sources

1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/